Hong Kong's IPO Revival Draws Chinese Industrial Giants and New Global Investors

Energy Drinks and Pork Producers Lead the Latest Wave

Eastroc Beverage, one of China's largest energy drink manufacturers, raised $1.3 billion through a Hong Kong secondary listing on February 3, 2026. As of February 7, Muyuan Foodstuff, the world's leading pork producer, was set to follow within days with a similar transaction worth $1.4 billion. Together, the two deals show how widely Hong Kong's fundraising revival now reaches across China's economy.

Hong Kong's stock exchange is experiencing its busiest period for initial public offerings in nearly half a decade, following a prolonged downturn associated with political unrest, the pandemic and weak investor confidence. An initial public offering, or IPO, is a sale of shares that brings a company onto a stock exchange. Many companies driving this recovery already trade elsewhere and are adding a Hong Kong listing to reach another pool of investors.

Contemporary Amperex Technology Co. Ltd. (CATL), the world's largest manufacturer of batteries for electric vehicles, supplied the clearest example of the revival's scale. Its $4.6 billion offering, completed in June 2025, was the world's largest IPO in the first half of that year and Hong Kong's biggest listing in four years. Its shares rose 16% on their debut.

Energy drinks, pork production and batteries are very different businesses. Their arrival in the same fundraising wave shows that Hong Kong's recovery extends beyond the internet platforms that dominated earlier listing booms. Mainland companies are seeking international capital closer to home as tensions between Washington and Beijing make American markets more difficult to navigate.

The Figures Behind the Recovery

Hong Kong hosted 42 main board IPOs in the first half of 2025, raising HK$107 billion, equivalent to $13.69 billion. That exceeded the entire annual fundraising total for 2024 and represented an increase of nearly 700% from the same period a year earlier. In simple terms, proceeds were almost eight times the previous first half total.

Figures compiled by PwC placed Hong Kong first globally for IPO fundraising in the first half of 2025, its first return to that position since 2019. The exchange's earlier record included seven consecutive years in first place within the period from 2009 to 2021.

The recovery also extended to other ways companies raise money from investors. Equity capital market issuance reached $45.5 billion in the first six months of 2025, up 152% from a year earlier. That broader measure includes IPOs, additional share sales by companies already listed and convertible bonds. A convertible bond is a loan to a company that can later be exchanged for shares under agreed conditions.

January fundraising through new listings reached approximately $5 billion, the highest total recorded for that month in Bloomberg's data. The early February transactions by Eastroc and Muyuan carried that momentum into another month.

Hong Kong had slipped out of the world's top five IPO venues during the downturn between 2022 and 2024, amid China's technology sector crackdown, geopolitical tensions and subdued investor sentiment. The recovery figures also include an annual tally of 71 new listings raising $11.2 billion, an increase of 88.9%, and a fourth place global ranking. Forecasts accompanying the 2025 rebound put potential fundraising above HK$200 billion, or $25 billion, for the full year, potentially reaching levels not seen since 2019.

Why Mainland Companies Are Choosing Hong Kong

Chinese companies face several pressures when considering American exchanges. These include the threat of delisting, scrutiny under the Holding Foreign Companies Accountable Act and the broader separation of parts of the American and Chinese economies. Delisting means losing a company's place on an exchange, making it harder for investors to trade its shares there.

Bonnie Chan, chief executive of Hong Kong Exchanges and Clearing, said more than 40 companies already listed through A shares in mainland China were considering secondary listings in Hong Kong. For those businesses, the city offers an offshore fundraising platform with access to international investors and less exposure to the political risks associated with American markets.

Xin Yao Ng, investment director on the Asian equities team at ABRDN, said global interest in China remained below levels seen before the pandemic because of structural geopolitical risks. Companies pursuing international expansion nevertheless have a reason to seek Hong Kong funding. CATL allocated 90% of its $4.6 billion raise to a manufacturing plant in Hungary, supporting its European expansion while working around potential trade barriers.

Ng also described the role of lower offer prices in attracting investors:

While the IPOs have generally been successful, most are coming at deep discounts, which makes valuations highly attractive for investors despite lingering concerns.

CATL's allocation amounted to about $4.14 billion for the Hungarian plant. Its example connects the fundraising revival to a concrete business purpose: financing production overseas rather than simply securing another stock market quotation.

How the A Plus H Strategy Works

Mainland companies are increasingly combining A shares, which trade on domestic exchanges such as Shanghai and Shenzhen, with H shares listed in Hong Kong. This arrangement allows the same company to raise money from different groups of investors and broaden its funding sources.

Eight companies using that structure raised more than HK$78 billion, roughly $10 billion, in the first half of 2025. They accounted for approximately 72% of Hong Kong's IPO proceeds during the period. Their contribution explains why the return of established mainland businesses has had such a large effect on the city's fundraising totals.

The Southbound Stock Connect programme allows mainland investors to buy Hong Kong shares through their existing domestic brokerage accounts. A Hong Kong listing can therefore reach investors inside mainland China as well as international institutions. Companies also gain access to funding in different currencies.

Prices for a company's A shares and H shares can differ. Those gaps make the structure attractive to sophisticated investors looking for potential returns from differences in valuation. For issuers, the appeal is a wider investor base; for buyers, it can include a lower price than the same company's mainland shares.

Wuxi Lead Intelligent Equipment, which makes industrial automation equipment, is seeking up to $549 million to expand its battery and solar cell manufacturing systems internationally. Seres Group, the electric vehicle manufacturer backed by Huawei Technologies, is preparing an offering of $1.5 billion to $2 billion. The streaming platform iQiyi, owned by Baidu and operating a service similar to Netflix, is exploring a $300 million secondary listing to reduce its reliance on American capital markets.

Industrial Businesses Replace the Earlier Internet Wave

Hong Kong's listing pipeline has changed since the boom of 2018 and 2019, when internet platforms and consumer technology businesses were prominent. The current wave features electric vehicle batteries, semiconductors, advanced manufacturing, healthcare innovation and clean energy technologies. Chinese policymakers group such activities under the term new productive forces.

Industrials led the first half of 2025 in IPO proceeds, followed by healthcare and technology. Across the broader equity capital market, healthcare issuance reached $5.8 billion, its highest level since 2021. Hong Kong's Chapter 18A listing framework supported that activity by allowing biotechnology companies that were not yet generating revenue to list.

The technology, media and telecom sector raised $13.7 billion. Investor interest in generative artificial intelligence, robotics and deep technology applications helped drive that total. Generative artificial intelligence refers to software that can produce content, such as text or images, in response to instructions.

Edward Tse, founder and chief executive of Gao Feng Advisory Company, described the recovery as different in its composition from previous cycles. Many businesses entering the market operate in strategic sectors aligned with national policy priorities. Established industrial champions feature more prominently than speculative startups.

Tse's assessment points to a more mature mix of issuers and a potentially more durable foundation for fundraising. The sector changes also connect Hong Kong's market recovery with Beijing's industrial agenda, particularly its support for advanced production and technologies used in energy and transport.

Regulators Adjust the Listing Rules

The China Securities Regulatory Commission introduced measures in early 2024 to streamline procedures for listings across borders and accelerate approvals for companies in priority sectors. Those measures marked a more practical regulatory approach after years of strict oversight that had weakened enthusiasm for new listings.

Hong Kong's exchange made complementary changes. It finalised improvements to Chapter 18A for biotechnology listings and introduced initiatives under Chapter 18C to attract specialist technology companies. The exchange also promised to complete reviews for large companies already listed in mainland China within 30 days.

Further changes took effect in August 2025. The minimum public float requirement for mainland Chinese companies seeking secondary listings fell from 15% to 10% of total shares. Public float is the portion of a company's shares available for public investors to hold and trade. A consultation was also underway on potentially reducing the requirement to 5% after listing.

The maximum allocation to retail investors in heavily subscribed IPOs dropped from 50% to 35%. Retail investors are individuals investing their own money, while institutional investors include investment funds and other large financial organisations. The change was intended to reduce price volatility and give institutions sufficient allocations to support price discovery, the process through which buying and selling establish a market price.

Dilin Wu, research strategist at broker Pepperstone, described the coordinated measures as a deliberate effort to make Hong Kong the main offshore fundraising hub for China's strategic sectors. Cooperation between mainland and Hong Kong regulators helped restore confidence among companies that had delayed listing plans because market conditions were uncertain.

Syngenta and Other Large Deals in the Pipeline

Syngenta Group is preparing a Hong Kong listing that could raise between $5 billion and $10 billion. The Swiss agrichemicals and seeds conglomerate is owned by Sinochem, which has Chinese state support. At the upper end of that range, its offering would be the third largest globally in the preceding five years, behind Rivian Automotive in 2021 and LG Energy Solution in 2022.

Syngenta originated from the merger of the agribusiness operations of Novartis and AstraZeneca and was later acquired by ChemChina for $43 billion. It competes with America's Corteva and Germany's BASF and Bayer. Choosing Hong Kong rather than New York or London reflects its strategic positioning and a desire to reduce geopolitical exposure.

The planned offering would use Regulation S, with shares not registered with the US Securities and Exchange Commission. The proposed structure is intended to avoid SEC oversight and exclude sales to American citizens. The potential $5 billion to $10 billion fundraising remains a planned transaction rather than a completed sale.

JD Industrials, the supply chain technology unit of the ecommerce group JD.com, has revived its application after earlier attempts lapsed in 2023 and 2024 because market conditions were unfavourable. It could raise between $500 million and $1 billion.

Unisound AI Technology has also returned to the listing queue after withdrawing an earlier application. Its renewed attempt comes amid greater optimism about artificial intelligence following breakthroughs by Chinese startup DeepSeek. Together with Syngenta and JD Industrials, it shows how improved sentiment is bringing postponed transactions back into consideration.

A Broader Investor Base Takes Shape

American and European asset managers have approached Hong Kong with caution. Their concerns include the National Security Law introduced in 2020, data security and questions about the territory's autonomy and legal reliability. Reduced participation from those investors has been offset by growing interest from other regions.

Middle Eastern sovereign wealth funds, which invest money on behalf of governments, have become more involved. Saudi Arabia's Public Investment Fund and the Abu Dhabi Investment Authority have signed cooperation agreements with Hong Kong financial institutions. The Saudi fund has committed up to $1 billion to a joint Hong Kong Saudi fund targeting companies with operations spanning Asia and the Middle East.

Funds from the region have taken anchor positions in major listings, including CATL and insurer FWD Group. An anchor investor commits money to a transaction early, helping a company build support for its share sale.

Singapore's Temasek Holdings and GIC have also become more active in Hong Kong IPOs. Thai coconut water company IFBH chose Hong Kong over the Singapore Exchange because of its stronger investor base in Greater China. Malaysian budget airline group Capital A is preparing a possible listing in the city in 2026.

More than 200 companies had filed applications with the exchange by the middle of 2025, compared with fewer than 100 a year earlier. The applicant pool also included a growing proportion of businesses from outside mainland China. Hong Kong's recovery is therefore drawing both new sources of investment and a wider range of prospective issuers.

Lower Valuations and Trading Risks

Many offerings have been priced at substantial discounts to the same companies' mainland A shares. Those prices can give investors a cheaper entry point, while leaving companies with the challenge of sustaining their valuations after trading begins. Chinese companies listed in Hong Kong trade at approximately 11 times estimated earnings, roughly half the valuation multiple of the S&P 500.

An earnings multiple compares a company's share price with the profit attributable to each share. At 11 times earnings, investors are paying about 11 units of price for each unit of expected annual profit. The comparison helps explain why lower valuations are part of Hong Kong's appeal even while geopolitical concerns persist.

Lawrence Lau, Greater China Financial Accounting Advisory Services Leader at Ernst & Young, has warned about insufficient trading activity in some stocks. If new listings arrive faster than investment money enters the market, weak liquidity could affect company valuations and share price performance. Liquidity means how easily investors can buy or sell shares.

The retail allocation changes address another market concern. Alongside reducing the maximum retail share from 50% to 35%, authorities introduced a cap on margin loans after the frenzied debut of Mixue Group. Margin loans let investors borrow money to increase their purchases, which can intensify demand for a popular offering.

The measures aim to limit overpricing and subsequent price declines seen in some heavily sought IPOs. They give more weight to institutional pricing decisions and may reduce the lottery style gains that previously attracted individuals to new listings. Strong fundraising and stable trading after a debut remain separate tasks for the exchange and its issuers.

The Dates That Shaped the Revival

Hong Kong's recovery developed through regulatory changes, returning applicants and increasingly large transactions. The sequence connects the weak market of earlier years with the latest consumer and agricultural listings.

• 2018 to 2019: Internet platforms and consumer technology featured prominently in Hong Kong's listing boom.
• 2020: The National Security Law became one of the concerns cited by cautious Western investors.
• 2022 to 2024: Hong Kong experienced a prolonged IPO downturn; JD Industrials' applications lapsed in 2023 and 2024.
• Early 2024: China's securities regulator introduced measures to simplify listings across borders and accelerate approvals in priority sectors.
• First half of 2025: Hong Kong raised HK$107 billion through 42 main board IPOs, returning to first place globally for fundraising.
• June 2025: CATL completed its $4.6 billion offering, with shares rising 16% on their debut.
• August 2025: Changes to public float requirements and retail allocations took effect.
• February 3, 2026: Eastroc Beverage raised $1.3 billion through its Hong Kong secondary listing.
• February 7, 2026: Muyuan Foodstuff was set to raise $1.4 billion within days; Capital A was preparing a possible listing during 2026.

Eastroc and Muyuan extend a revival already built around large industrial companies. Its next stage depends on converting the substantial application pipeline into completed offerings while attracting enough investment and trading activity to support the expanding market.

Key Points

• Hong Kong's 42 main board IPOs raised HK$107 billion, or $13.69 billion, in the first half of 2025, an increase of nearly 700%.
• Eight companies combining mainland A shares with Hong Kong H shares supplied about 72% of those proceeds.
• CATL raised $4.6 billion and allocated 90% to its Hungarian manufacturing plant.
• Eastroc Beverage raised $1.3 billion on February 3, 2026; Muyuan Foodstuff was preparing a $1.4 billion transaction.
• Regulatory changes reduced the minimum public float requirement from 15% to 10% and the maximum retail allocation in popular IPOs from 50% to 35%.
• Syngenta is preparing a potential $5 billion to $10 billion offering, while Seres, JD Industrials and other companies are pursuing listings.
• Middle Eastern and Southeast Asian investors are becoming more active as Western institutions remain cautious.
• Discounted valuations attract buyers, while limited trading activity and a growing supply of shares remain challenges.